ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ANTM - US0367521038 - Common Stock
304.2 EUR
+2.7 (+0.9%)
Taking everything into account, 1ANTM scores 4 out of 10 in our fundamental rating. 1ANTM was compared to 27 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of 1ANTM while its profitability can be described as average. 1ANTM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 1ANTM was profitable.
1ANTM had a positive operating cash flow in the past year.
In the past 5 years 1ANTM has always been profitable.
1ANTM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 1ANTM (4.40%) is better than 77.14% of its industry peers.
1ANTM has a Return On Equity (12.26%) which is in line with its industry peers.
1ANTM has a Return On Invested Capital (5.90%) which is comparable to the rest of the industry.
1ANTM had an Average Return On Invested Capital over the past 3 years of 6.90%. This is in line with the industry average of 6.91%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROIC | 5.9% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
1ANTM's Profit Margin of 2.83% is in line compared to the rest of the industry. 1ANTM outperforms 57.14% of its industry peers.
1ANTM's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 4.60%, 1ANTM is in line with its industry, outperforming 48.57% of the companies in the same industry.
1ANTM's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ANTM is destroying value.
1ANTM has less shares outstanding than it did 1 year ago.
1ANTM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1ANTM is higher compared to a year ago.
2.2 Solvency
1ANTM has a debt to FCF ratio of 5.70. This is a neutral value as 1ANTM would need 5.70 years to pay back of all of its debts.
1ANTM has a better Debt to FCF ratio (5.70) than 71.43% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that 1ANTM is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.65, 1ANTM is doing good in the industry, outperforming 74.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Altman-Z | N/A |
ROIC/WACC0.73
WACC8.12%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
The earnings per share for 1ANTM have decreased by -6.64% in the last year.
The Earnings Per Share has been growing by 11.17% on average over the past years. This is quite good.
The Revenue has grown by 10.21% in the past year. This is quite good.
1ANTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
3.2 Future
1ANTM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.89% yearly.
1ANTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.96% yearly.
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.76, the valuation of 1ANTM can be described as very reasonable.
Based on the Price/Earnings ratio, 1ANTM is valued cheaply inside the industry as 82.86% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 1ANTM to the average of the S&P500 Index (25.65), we can say 1ANTM is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.27, the valuation of 1ANTM can be described as very reasonable.
Based on the Price/Forward Earnings ratio, 1ANTM is valued a bit cheaper than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.45, 1ANTM is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.76 | ||
| Fwd PE | 11.27 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ANTM is on the same level as its industry peers.
1ANTM's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.12 | ||
| EV/EBITDA | 9.95 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y-2.2%
EPS Next 3Y3%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.96%, 1ANTM has a reasonable but not impressive dividend return.
1ANTM's Dividend Yield is a higher than the industry average which is at 2.09.
Compared to an average S&P500 Dividend Yield of 2.41, 1ANTM has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
5.2 History
On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
28.40% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y-2.2%
EPS Next 3Y3%
BIT:1ANTM (10/10/2025, 7:00:00 PM)
304.2
+2.7 (+0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap68.50B
Revenue(TTM)189.25B
Net Income(TTM)5.36B
Analysts76.43
Price Target317.97 (4.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
Yearly Dividend5.61
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-24.27%
PT rev (3m)-34.19%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)-42.5%
EPS NY rev (1m)-13.11%
EPS NY rev (3m)-12.64%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.76 | ||
| Fwd PE | 11.27 | ||
| P/S | 0.42 | ||
| P/FCF | 15.12 | ||
| P/OCF | 12.48 | ||
| P/B | 1.83 | ||
| P/tB | 20.71 | ||
| EV/EBITDA | 9.95 |
EPS(TTM)28.27
EY9.29%
EPS(NY)27
Fwd EY8.87%
FCF(TTM)20.12
FCFY6.61%
OCF(TTM)24.37
OCFY8.01%
SpS719.51
BVpS166.22
TBVpS14.69
PEG (NY)N/A
PEG (5Y)0.96
Graham Number325.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROCE | 7.72% | ||
| ROIC | 5.9% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 11.77% | ||
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A | ||
| FCFM | 2.8% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 75.47% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.96% | ||
| Profit Quality | 98.73% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC8.12%
ROIC/WACC0.73
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / 1ANTM.MI FAQ
What is the ChartMill fundamental rating of ELEVANCE HEALTH INC (1ANTM.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI.
What is the valuation status for 1ANTM stock?
ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (1ANTM.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for ELEVANCE HEALTH INC?
ELEVANCE HEALTH INC (1ANTM.MI) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ELEVANCE HEALTH INC (1ANTM.MI) stock?
The Price/Earnings (PE) ratio for ELEVANCE HEALTH INC (1ANTM.MI) is 10.76 and the Price/Book (PB) ratio is 1.83.
Can you provide the financial health for 1ANTM stock?
The financial health rating of ELEVANCE HEALTH INC (1ANTM.MI) is 3 / 10.